CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
single photon emission computed tomographyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02280941
NCT02280941N/ACompleted
CompareCT.gov

Comparison of Myocardial Blood Flow Measurements With Dedicated Solid State SPECT Camera Imaging and 99mTc-Tetrofosmin Versus PET Imaging and Rubidium-82

Ottawa Heart Institute Research Corporation·interventional·Posted Nov 3, 2014·Updated Apr 6, 2025

In Brief

A clinical study evaluating single photon emission computed tomography for Coronary Heart Disease. Completed, enrolled 66 participants across 1 site.

Detailed Summary

This study is being done to compare the blood flow measurements obtained with the SPECT and PET imaging scans. Measurements such as myocardial blood flow (MBF) and myocardial flow reserve (MFR) are analyzed on PET scans. These measurements give the doctors more precise information in diagnosing heart problems. SPECT scans, with new camera technology and computer software, now have the potential to also give this additional information. The study is investigating how well the blood flow measurements from SPECT compared to PET.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Heart Disease
CountriesCanada
CollaboratorsGE Healthcare

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 3, 2014
Enrollment StartOct 30, 2014
Primary CompletionSep 2, 2022
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 11.7 years ago

Interventions

single photon emission computed tomographyother

Single photon emission computed tomography (SPECT) imaging will be done.